Compound Evidence File
#EC-2026-0922
PTD-DBM
Filed under Peptides. The bureau holds 238 laboratory returns for this compound from 98 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
98 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 25 May 2026 | 25 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 9.9 | 10.0 | 22 Nov 2025 | 28 Apr 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 10.0 | 9.9 | 10.0 | 1 Nov 2025 | 12 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 9.9 | 10.0 | 15 Dec 2025 | 16 May 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 9.9 | 10.0 | 13 Mar 2026 | 14 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 10.0 | 9.9 | 10.0 | 22 May 2026 | 22 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 9.9 | 10.0 | 28 Feb 2026 | 3 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 7 Mar 2026 | 8 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 9.9 | 10.0 | 2 Jan 2026 | 28 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 2 May 2026 | 13 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 10.0 | 9.9 | 10.0 | 19 Dec 2025 | 3 Apr 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 10.0 | 10.0 | 21 Jan 2026 | 13 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 10.0 | 10.0 | 10.0 | 5 Jun 2026 | 11 Jul 2026 |
| Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 | X | 1 | 10.0 | 10.0 | 10.0 | 3 Jun 2025 | 3 Jun 2025 |
| NUPEPS PeptidesCASE #VI-2026-0896 | X | 1 | 10.0 | 10.0 | 10.0 | 3 Jun 2025 | 3 Jun 2025 |
| Trusted PeptideCASE #VI-2026-0499 | X | 1 | 10.0 | 10.0 | 10.0 | 13 Jun 2025 | 13 Jun 2025 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 12 Mar 2026 | 11 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 24 Mar 2026 | 26 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 9.9 | 9.9 | 10.0 | 18 Apr 2026 | 21 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Jan 2026 | 4 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 9.9 | 9.9 | 10.0 | 11 Feb 2026 | 5 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 9.9 | 9.9 | 10.0 | 12 Nov 2025 | 23 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 9.9 | 9.9 | 10.0 | 21 Feb 2026 | 4 Apr 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 9.9 | 5 Dec 2025 | 12 Apr 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 9.9 | 25 Apr 2026 | 10 May 2026 |
| NextGen HealthCASE #VI-2026-0604 | X | 1 | 9.9 | 9.9 | 9.9 | 20 Jun 2025 | 20 Jun 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 4 | 9.2 | 8.2 | 10.0 | 24 May 2026 | 24 May 2026 |
| Atomik LabzCASE #VI-2026-0327 | X | 3 | 9.2 | 7.7 | 10.0 | 24 Apr 2025 | 20 May 2026 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 9.0 | 9.0 | 9.0 | 8 Jul 2025 | 8 Jul 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 5 | 8.8 | 7.0 | 9.8 | 21 May 2026 | 21 May 2026 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 8.8 | 8.8 | 8.8 | 14 Jan 2025 | 14 Jan 2025 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 8.7 | 8.7 | 8.7 | 9 Jun 2025 | 9 Jun 2025 |
| Royal PeptidesCASE #VI-2026-0264 | X | 2 | 8.6 | 7.1 | 10.0 | 14 Jan 2025 | 26 Jan 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 5 | 8.5 | 6.9 | 9.8 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 8.4 | 7.4 | 9.1 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 8.4 | 6.6 | 9.4 | 21 May 2026 | 21 May 2026 |
| UtherCASE #VI-2026-0902 | X | 5 | 8.1 | 5.7 | 9.5 | 17 Dec 2024 | 23 May 2026 |
| Planet PeptideCASE #VI-2026-0092 | X | 2 | 8.1 | 7.0 | 9.1 | 13 Feb 2025 | 21 May 2026 |
| Zztai PeptideCASE #VI-2026-0192 | C | 3 | 7.9 | 6.9 | 9.8 | 13 Jun 2025 | 17 May 2026 |
| Xingtai Jiachuang TechnologyCASE #VI-2026-0712 | X | 1 | 7.9 | 7.9 | 7.9 | 3 Jun 2025 | 3 Jun 2025 |
| Peptide PartnersCASE #VI-2026-0295 | X | 6 | 7.8 | 4.7 | 9.5 | 20 Jun 2025 | 23 May 2026 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 7.8 | 7.8 | 7.8 | 25 Apr 2025 | 25 Apr 2025 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 2 | 7.7 | 7.5 | 7.8 | 14 Jan 2025 | 23 May 2026 |
| Top PeptideCASE #VI-2026-0721 | X | 1 | 7.7 | 7.7 | 7.7 | 25 Apr 2025 | 25 Apr 2025 |
| M-PeptidesCASE #VI-2026-0442 | X | 1 | 7.6 | 7.6 | 7.6 | 9 Jun 2025 | 9 Jun 2025 |
| Hunan Ruiwang Technology CenterCASE #VI-2026-0027 | X | 1 | 7.6 | 7.6 | 7.6 | 11 Jun 2025 | 11 Jun 2025 |
| HealthTide BiotechCASE #VI-2026-0955 | X | 1 | 7.6 | 7.6 | 7.6 | 2 Apr 2025 | 2 Apr 2025 |
| Peptide WorldwideCASE #VI-2026-0217 | X | 1 | 7.5 | 7.5 | 7.5 | 16 Mar 2025 | 16 Mar 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 7.5 | 7.5 | 7.5 | 2 Jul 2025 | 2 Jul 2025 |
| Peptide-SCASE #VI-2026-0111 | X | 8 | 7.3 | 4.4 | 9.4 | 20 Jun 2025 | 21 May 2026 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 7.3 | 7.3 | 7.3 | 24 Apr 2025 | 24 Apr 2025 |
| OupeptideCASE #VI-2026-0435 | X | 9 | 7.2 | 5.1 | 8.8 | 9 Jun 2025 | 21 May 2026 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 2 | 7.2 | 5.4 | 8.9 | 27 Feb 2025 | 25 May 2026 |
| Modern AminosCASE #VI-2026-0635 | X | 1 | 7.1 | 7.1 | 7.1 | 16 Mar 2025 | 16 Mar 2025 |
| ZZQ PeptidesCASE #VI-2026-0550 | E | 2 | 7.0 | 6.6 | 7.4 | 24 Apr 2025 | 19 Jan 2026 |
| Xingruida XDRCASE #VI-2026-0898 | X | 3 | 7.0 | 6.2 | 8.6 | 3 Jun 2025 | 17 May 2026 |
| Kits4lessCASE #VI-2026-0744 | X | 1 | 7.0 | 7.0 | 7.0 | 2 Jul 2025 | 2 Jul 2025 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 5 | 6.9 | 5.2 | 8.1 | 21 May 2025 | 24 May 2026 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | X | 2 | 6.8 | 6.3 | 7.4 | 28 Mar 2025 | 24 May 2026 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 2 | 6.8 | 6.7 | 6.9 | 2 Apr 2025 | 24 May 2026 |
| BfflinkCASE #VI-2026-0212 | X | 1 | 6.7 | 6.7 | 6.7 | 11 Jun 2025 | 11 Jun 2025 |
| Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 | X | 4 | 6.6 | 5.1 | 10.0 | 20 Jun 2025 | 19 Jan 2026 |
| Yabang PeptideCASE #VI-2026-0148 | X | 1 | 6.5 | 6.5 | 6.5 | 20 Jun 2025 | 20 Jun 2025 |
| Simple PeptideCASE #VI-2026-0782 | X | 2 | 6.4 | 4.8 | 8.0 | 27 Feb 2025 | 20 May 2026 |
| InjectifyCASE #VI-2026-0387 | X | 1 | 6.4 | 6.4 | 6.4 | 16 Mar 2025 | 16 Mar 2025 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 7 | 6.3 | 3.7 | 9.2 | 16 Mar 2025 | 21 May 2026 |
| Elite Research USACASE #VI-2026-0267 | X | 3 | 6.3 | 6.0 | 6.9 | 7 May 2025 | 23 May 2026 |
| Kerisite Shenzhen InternationalCASE #VI-2026-0315 | X | 1 | 6.2 | 6.2 | 6.2 | 28 Mar 2025 | 28 Mar 2025 |
| Peptide TechnologiesCASE #VI-2026-0694 | X | 1 | 6.1 | 6.1 | 6.1 | 6 May 2025 | 6 May 2025 |
| Heman Peptide HMCASE #VI-2026-0089 | X | 1 | 6.1 | 6.1 | 6.1 | 7 May 2025 | 7 May 2025 |
| Anlv BiotechnologyCASE #VI-2026-0110 | X | 1 | 6.1 | 6.1 | 6.1 | 9 Jun 2025 | 9 Jun 2025 |
| NexaphCASE #VI-2026-0944 | X | 3 | 6.0 | 4.3 | 7.8 | 2 Apr 2025 | 25 May 2026 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 2 | 6.0 | 5.7 | 6.3 | 25 Apr 2025 | 17 May 2026 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | X | 1 | 6.0 | 6.0 | 6.0 | 11 Jun 2025 | 11 Jun 2025 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 6.0 | 6.0 | 6.0 | 6 May 2025 | 6 May 2025 |
| Reta-PeptideCASE #VI-2026-0756 | X | 1 | 5.5 | 5.5 | 5.5 | 11 Jun 2025 | 11 Jun 2025 |
| Oasis PeptidesCASE #VI-2026-0404 | X | 1 | 5.4 | 5.4 | 5.4 | 16 Mar 2025 | 16 Mar 2025 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 5.0 | 5.0 | 5.0 | 27 Feb 2025 | 27 Feb 2025 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 5.0 | 5.0 | 5.0 | 28 Mar 2025 | 28 Mar 2025 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 4.8 | 4.8 | 4.8 | 16 Mar 2025 | 16 Mar 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 2 | 4.6 | 2.2 | 7.0 | 25 Apr 2025 | 25 May 2026 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 4.5 | 4.5 | 4.5 | 6 May 2025 | 6 May 2025 |
| Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 | X | 1 | 4.0 | 4.0 | 4.0 | 8 Jul 2025 | 8 Jul 2025 |
| Loti LabsCASE #VI-2026-0171 | X | 3 | 3.9 | 1.4 | 6.3 | 11 Jun 2025 | 23 May 2026 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 3.9 | 3.9 | 3.9 | 11 Jun 2025 | 11 Jun 2025 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 3.8 | 3.8 | 3.8 | 9 Jun 2025 | 9 Jun 2025 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 3.5 | 3.5 | 3.5 | 13 Feb 2025 | 13 Feb 2025 |
| Biolabshop LimitedCASE #VI-2026-0832 | X | 1 | 3.3 | 3.3 | 3.3 | 3 Jun 2025 | 3 Jun 2025 |
| Shaanxi Dideu MedichemCASE #VI-2026-0499 | X | 1 | 2.7 | 2.7 | 2.7 | 3 Jul 2025 | 3 Jul 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 1.9 | 1.9 | 1.9 | 27 Feb 2025 | 27 Feb 2025 |
| PRIVATECASE #VI-2026-0635 | X | 1 | 1.4 | 1.4 | 1.4 | 27 Feb 2025 | 27 Feb 2025 |
| DeuschemCASE #VI-2026-0004 | X | 2 | 1.2 | 0.7 | 1.7 | 25 Apr 2025 | 24 May 2026 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.3 | 0.3 | 0.3 | 28 Mar 2025 | 28 Mar 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 0.0 | 0.0 | 0.0 | 13 Jun 2025 | 13 Jun 2025 |
| HK Fat CatCASE #VI-2026-0376 | X | 1 | 0.0 | 0.0 | 0.0 | 13 Jun 2025 | 13 Jun 2025 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 0.0 | 0.0 | 0.0 | 21 May 2025 | 21 May 2025 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 0.0 | 0.0 | 0.0 | 14 Jan 2025 | 14 Jan 2025 |
Open any subject to view the batch-level evidence for PTD-DBM alone.